These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18560037)

  • 1. [Biopharmaceutic and technological investigation of vagina suppositories containing brilliant green].
    Dzhavakhiia MSh; Churadze LI; Iavich PA
    Georgian Med News; 2008 May; (158):33-6. PubMed ID: 18560037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Technology of vitamins containing double layer suppositories].
    Bakuridze AD; Maglakelidze GM; Kurdiani NG; Tsagareishvili NT; Berashvili DT
    Georgian Med News; 2008 May; (158):49-51. PubMed ID: 18560041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Formulation and analysis of suppositories containing papaverine hydrochloride. Part 1. Choice of the optimal vehicle and determination of the physical parameters of the suppositories].
    Regdon G; Vastag T; Regdon G; Selmeczi B
    Acta Pharm Hung; 1991 Nov; 61(6):295-302. PubMed ID: 1785358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppositories formulation and drug release.
    Moes AJ
    Boll Chim Farm; 1989 Jan; 128(1):5-12. PubMed ID: 2673303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biopharmaceutical study of aminophenazone-containing suppositories. 2. Results of in vitro drug release and in vivo drug absorption].
    Tantó M; Ecsy Z; Selmeczi B; Regdon G
    Acta Pharm Hung; 1990 Jul; 60(4):149-55. PubMed ID: 2239342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acetaminophen-containing suppositories in vitro and in vivo].
    Regdon G; Szikszay M; Gebri G; Regdon G
    Acta Pharm Hung; 1994 Mar; 64(2):45-9. PubMed ID: 8017207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapidly disintegrating vagina retentive cream suppositories of progesterone: development, patient satisfaction and in vitro/in vivo studies.
    Bendas ER; Basalious EB
    Pharm Dev Technol; 2016; 21(3):288-95. PubMed ID: 25567033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of surfactant characteristics on drug availability from suppositories.
    Realdon N; Dal Zotto M; Morpurgo M; Franceschinis E
    Pharmazie; 2008 Jun; 63(6):459-63. PubMed ID: 18604990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and safety of vaginal suppositories for the treatment of the vaginal atrophy in postmenopausal women: an open, non-controlled clinical trial.
    Costantino D; Guaraldi C
    Eur Rev Med Pharmacol Sci; 2008; 12(6):411-6. PubMed ID: 19146203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Formulation and analysis of suppositories containing papaverine hydrochloride. Part 2. In vitro membrane diffusion studies].
    Regdon G; Vastag T; Regdon G; Selmeczi B
    Acta Pharm Hung; 1991 Nov; 61(6):303-9. PubMed ID: 1785359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of an acetic acid ester of monoglyceride as a suppository base with unique properties.
    Dash AK; Cudworth GC
    AAPS PharmSciTech; 2001 Jul; 2(3):E13. PubMed ID: 14727872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro release of chloramphenicol from different suppository bases.
    Kassem AA; Nour El-Din E; Abd El-Bary A; Fadel HM
    Pharmazie; 1975 Jul; 30(7):472-5. PubMed ID: 1178767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the relationship between melting-related parameters and in vitro drug release from vaginal suppositories.
    Bergren MS; Battle MM; Halstead GW; Theis DL
    J Pharm Biomed Anal; 1989; 7(5):549-61. PubMed ID: 2490759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preparation and in vitro study of suppositories containing No-Spa. II. Determination of release of the active principle by membrane diffusion methods].
    Regdon G; Kovács B; Pécsiné Szebellédi I; Regdon G
    Acta Pharm Hung; 1989 Jan; 59(1):32-41. PubMed ID: 2711839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and evaluation of a suppository formulation containing Lactobacillus and its application in vaginal diseases.
    Kale VV; Trivedi RV; Wate SP; Bhusari KP
    Ann N Y Acad Sci; 2005 Nov; 1056():359-65. PubMed ID: 16387701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro evaluation and vaginal absorption of metronidazole suppositories in rabbits.
    Ozyazici M; Turgut EH; Taner MS; Köseoglu K; Ertan G
    J Drug Target; 2003 Apr; 11(3):177-85. PubMed ID: 14577974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Formulation and in vitro investigation of antibacterial vaginal suppositories. Part 1. Considerations in selecting the vehicle. Methods and results of the physical examination].
    Tariné Gombkötö Z; Regdon G; Regdon G; Selmeczi B
    Acta Pharm Hung; 1992 Nov; 62(6):295-301. PubMed ID: 1488915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biopharmaceutical studies on vaginal suppositories containing antibiotics and antimycotics].
    Török J; Sallay J; Altmayer P
    Pharmazie; 1982 Aug; 37(8):600-2. PubMed ID: 7146069
    [No Abstract]   [Full Text] [Related]  

  • 19. [Biopharmaceutical study of aminophenazone-containing suppositories. 1. Experimental materials and methods, determination of physical qualities of the suppositories].
    Tantó M; Ecsy Z; Selmeczi B; Regdon G
    Acta Pharm Hung; 1990 Jul; 60(4):143-8. PubMed ID: 2239341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug therapy in control of pains in gynecology].
    Schleith K
    Med Welt; 1966 Jul; 28():1522-4. PubMed ID: 5984512
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.